PMC:7212965 / 1392-1559 JSONTXT

Annnotations TAB JSON ListView MergeView

    LitCovid-PD-MONDO

    {"project":"LitCovid-PD-MONDO","denotations":[{"id":"T8","span":{"begin":68,"end":76},"obj":"Disease"}],"attributes":[{"id":"A8","pred":"mondo_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/MONDO_0001673"}],"text":"tients. Pooled prevalence estimates of GI symptoms were as follows: diarrhea 7.7% (95% confidence interval [CI], 7.2%–8.2%), nausea/vomiting 7.8% (95% CI, 7.1%–8.5%), "}

    LitCovid-PD-CHEBI

    {"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T3","span":{"begin":39,"end":41},"obj":"Chemical"}],"attributes":[{"id":"A3","pred":"chebi_id","subj":"T3","obj":"http://purl.obolibrary.org/obo/CHEBI_73907"}],"text":"tients. Pooled prevalence estimates of GI symptoms were as follows: diarrhea 7.7% (95% confidence interval [CI], 7.2%–8.2%), nausea/vomiting 7.8% (95% CI, 7.1%–8.5%), "}

    LitCovid-PD-HP

    {"project":"LitCovid-PD-HP","denotations":[{"id":"T7","span":{"begin":68,"end":76},"obj":"Phenotype"},{"id":"T8","span":{"begin":125,"end":140},"obj":"Phenotype"}],"attributes":[{"id":"A7","pred":"hp_id","subj":"T7","obj":"http://purl.obolibrary.org/obo/HP_0002014"},{"id":"A8","pred":"hp_id","subj":"T8","obj":"http://purl.obolibrary.org/obo/HP_0002017"}],"text":"tients. Pooled prevalence estimates of GI symptoms were as follows: diarrhea 7.7% (95% confidence interval [CI], 7.2%–8.2%), nausea/vomiting 7.8% (95% CI, 7.1%–8.5%), "}

    LitCovid-PubTator

    {"project":"LitCovid-PubTator","denotations":[{"id":"54","span":{"begin":39,"end":41},"obj":"Gene"},{"id":"57","span":{"begin":68,"end":76},"obj":"Disease"},{"id":"58","span":{"begin":125,"end":131},"obj":"Disease"},{"id":"59","span":{"begin":132,"end":140},"obj":"Disease"}],"attributes":[{"id":"A54","pred":"tao:has_database_id","subj":"54","obj":"Gene:2770"},{"id":"A57","pred":"tao:has_database_id","subj":"57","obj":"MESH:D003967"},{"id":"A58","pred":"tao:has_database_id","subj":"58","obj":"MESH:D009325"},{"id":"A59","pred":"tao:has_database_id","subj":"59","obj":"MESH:D014839"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"tients. Pooled prevalence estimates of GI symptoms were as follows: diarrhea 7.7% (95% confidence interval [CI], 7.2%–8.2%), nausea/vomiting 7.8% (95% CI, 7.1%–8.5%), "}